AXA IM and BNPP AM are progressively merging and streamlining our legal entities to create a unified structure. Whilst this is ongoing, we will continue to operate two seperate websites both branded BNPP AM. Learn more. 

Arjun Kandola

Investment Analyst of Healthcare Private Equity
AXA IM Alts is part of the BNP Paribas Group

Arjun joined the AXA IM Alts team in 2024 and brings experience across both venture capital and strategy consulting. Prior to joining, Arjun spent three years at L.E.K. Consulting, within the firm's Life Sciences practice. In this role, he completed a variety of strategy and diligence projects on behalf of corporate and private equity clients respectively.

Prior to L.E.K., Arjun spent two years in venture capital across two funds, Force Over Mass Capital and TenX Health. In these roles, he focused on deal origination and execution within Tech and HealthTech respectively.

Arjun holds an MSci in Computational Biology and Biochemistry from University College London.

    AXA IM and BNPP AM are progressively merging

    AXA IM and BNPP AM are progressively merging and streamlining our legal entities to create a unified structure

    AXA Investment Managers joined BNP Paribas Group in July 2025. Following the merger of AXA Investment Managers Paris and BNP PARIBAS ASSET MANAGEMENT Europe and their respective holding companies on December 31, 2025, the combined company now operates under the BNP PARIBAS ASSET MANAGEMENT Europe name.